These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 6980948)

  • 1. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T; Cooper MD; Balch CM
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
    Abo T; Miller CA; Balch CM
    Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro propagation of cultured human natural killer cells expressing the HNK-1 differentiation antigen and spontaneous cytotoxic function.
    Abo T; Balch CM
    Eur J Immunol; 1983 May; 13(5):383-9. PubMed ID: 6406236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells.
    Abo T; Balch CM
    J Immunol; 1982 Oct; 129(4):1758-61. PubMed ID: 7108226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.
    Abo T; Miller CA; Gartland GL; Balch CM
    J Exp Med; 1983 Jan; 157(1):273-84. PubMed ID: 6848618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
    Rumpold H; Kraft D; Gastl G; Huber C
    Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human K cells by surface antigens and morphology at the single cell level.
    Wåhlin B; Perlmann P
    J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
    Tilden AB; Abo T; Balch CM
    J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
    J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
    Abo T; Balch CM
    J Immunol; 1981 Sep; 127(3):1024-9. PubMed ID: 6790607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiation.
    Zambello R; Chisesi T; De Rossi G; Pandolfi F; Trentin L; Vespignani M; Luciani M; Cafaro A; Agostini C; Martelli M
    J Clin Lab Immunol; 1986 Jul; 20(3):107-11. PubMed ID: 3746877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
    Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
    J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
    Lopez-Botet M; Moretta L
    J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characteristics of human natural killer cells.
    Perussia B; London L; Trinchieri G
    Biomed Pharmacother; 1985; 39(1):13-8. PubMed ID: 3875369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
    J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.